Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis

British Journal of Dermatology

Volumn 140, Issue 1, 1999, Pages 67-72

  Furue, Masutaka ^a   Koga, T ^b   Yamashita, N ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atopic dermatitis; Eosinophil cationic protein; Serum markers; Soluble E selectin

Indexed keywords

CD14 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; INTERLEUKIN 4;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ECZEMA; EOSINOPHIL; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; URTICARIA;

ADOLESCENT; ADULT; ANTIGENS, CD14; BIOLOGICAL MARKERS; BLOOD PROTEINS; DERMATITIS, ATOPIC; E-SELECTIN; EOSINOPHIL GRANULE PROTEINS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-4; MALE; RIBONUCLEASES; SOLUBILITY;

EID: 0033011579     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02609.x     Document Type: Article

References (29)

1. Furue M. Atopic dermatitis, immunological abnormality and its background. J Dermatol Sci 1994; 7: 159-68.
2. Hanifin JM. Atopic dermatitis. J Am Acad Dermatol 1982; 6: 1-11.
3. Leiferman KM. A current perspective on the role of eosinophils in dermatologic diseases. J Am Acad Dermatol 1991; 24: 1101-12.
4. Sillevis Smith JH, Bos JD, Hulsebosch HJ et al. In situ immunotyping of antigen presenting cells and T subsets in atopic dermatitis. Clin Exp Dermatol 1986; 11: 159-68.
5. Cooper KD. Atopic dermatitis: Recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102: 128-37.
6. Springer TA. Traffic signal for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301-14.
7. Weller PF, Rand TH, Goelz SE et al. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule. Proc Natl Acad Sci USA 1991; 88: 7430- 3.
8. Petzelbauer P, Bender JR, Wilson J et al. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 1993; 151: 5062-72.
9. Gearing AJH. Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-12.
10. Kowalzick L, Kleinheinz A, Neuber K et al. Elevated serum levels of soluble adhesion molecules ICAM-1 and ELAM-1 in patients with severe atopic eczema and influence of UVA1 treatment. Dermatology 1995; 190: 14-18.
11. Czech W, Schopf E, Kapp A. Soluble E-selectin in sera of patients with atopic dermatitis trod psoriasis - Correlation with disease activity. Br J Dermatol 1996; 134: 17-21.
12. Yamashita Y, Kaneko S, Kuuro O et al. Soluble E-selectin as a marker of disease activity in atopic dermatitis. J Allergy Clin Immunol 1997; 99: 410-16.
13. Wüthrich B, Joller-Jemelka H, Kagi MK. Levels of soluble ICAM-1 in atopic dermatitis. A new marker for monitoring the clinical activity? Allergy 1995; 50: 88-9.
14. Kapsenberg ML, Wierenga EA, Bos JD et al. Functional subsets of allergen-reactive human CD4+ T cells. Immunol Today 1991; 12: 392-5.
15. Thornhill MH, Huskard DO. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J Immunol 1990: 145: 865-72.
16. Matsumoto T, Miike T, Yamaguchi K et al. Serum levels of soluble IL-2 receptor, IL-4, mid IgE-binding factors in childhnod allergic diseases. Clin Exp J Immunol 1991; 85: 288-92.
17. Furue M, Sugiyama H, Tsukamoto K et al. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis. J Dermatol Sci 1994; 7: 89-95.
18. Miyasato M, Tsuda S, Nakama T et al. Serum levels of eosinophil cationic protein reflect the state of in vitro degranulation of blood hypodense eosinophils in atopic dermatitis. J Dermatol 1996; 23: 382-8.
19. Wüthrich B, Kagi MK, Joller-Jemelka H. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res 1992; 284: 339-42.
20. Japanese Dermatological Association. Criteria for the diagnosis of atopic dermatitis. Jpn J Dermatol 1996; 106: 64-5.
21. Ohshima Y, Katamura K, Miura M et al. Serum levels of interleukin 4 and soluble CD23 in children with allergic disorders. Eur J Pediatr 1995; 154: 723-8.
22. Groves RW, Allen MH, Barker JN et al. Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in inflammation. Br J Dermatol 1991; 124: 117-23.
23. Wakita H, Sakamoto T, Tokura Y et al. E-selectin and vascular cell adhesion molecule-1 as critical adhesion molecules for infiltration of T lymphocytes and eosinophils in atopic dermatitis. J Cutan Pathol 1994; 21: 33-9.
24. Wakugawa M, Nakagawa H, Yamada N et al. Chronologic analysis of eosinophil granule protein deposition and cell adhesion molecule expression in mite allergen-induced dermatitis in atopic subjects. Int Arch Allergy Immunol 1996; 111: 5-11.
25. Jung K, Linse E, Heller R et al. Adhesion molecules in atopic dermatitis: VCAM-1 and ICAM-1 expression is increased in healthy-appearing skin. Allergy 1996; 51: 452-60.
26. Picker LJ, Michie SA, Roll LS et al. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990; 136: 1053-68.
27. Picker LJ, Kishimoto TK, Smith CW et al. ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 1991; 349: 796-9.
28. Berg EL, Yoshino T, Rott LS et al. The cutanenus lymphocyte antigen is a skin lymphocyte homing receptor for the vascular leclin endothelial cell-leukocyte adhesion molecule. 1. J Exp Med 1991; 174: 1461-6.
29. 2) on human neutrophils. J Exp Med 1991; 173: 1493-500.